Parkinson’s disease: treatment of early stage disease

Written by Rosinskaya A.V., Datieva V.K.

  Индекс УДК: 616.858‑085.21 | Страницы: 55-59 | Полный текст статьи. PDF файл | Открыть PDF 


The paper reviews the literature data related to the treatment of early Parkinson›s disease and discusses the advantages and disadvantages of monotherapy, principles of drug selection, features of treatment of patients of different ages, and the use of new form of pramipexole with sustained release.

Ссылки на авторов:

A.V. Rosinskaya
Primorsky Regional Clinical Hospital No. 1 (57 Aleutskaya St. Vladivostok 690091 Russian Federation)
V.K. Datieva
Russian Medical Academy of Post-Graduate Education (5 2nd Botkinsky Proezd Moscow 123995 Russian Federation)

  1. Golubev V.L., Levin Ya.I., Vein A.M. Parkinson’s disease and Parkinson’s syndrome. M.: MEDpress, 1999. 416 p.
  2. Levin O.S., Fedorova N.V., Smolentseva I.G. Dopamine receptor agonists in the treatment of Parkinson’s disease // Russian Medical Journal. 2000. No. 15–16. P. 643–646.
  3. Levin O.S., Fedorova N.V. Parkinson’s disease. M.: MED‑press-inform, 2011. 351 p.
  4. Treatment protocol. Parkinson’s disease // Problems of standardization in Public Health. 2005. No. 3. P. 74–166.
  5. Chwieduk C.M., Curran M.P. Pramipexole extended release in Parkinson’s disease // CNS Drugs. 2010. Vol. 24. P. 327–336.
  6. Grosset K.A., Bone I., Grosset D.G. Suboptimal Medication Adherence in Parkinson’s Disease // Mov. Disord. 2005. Vol. 20, No. 11. P. 1502–1507.
  7. Hauser R., Salin L., Koester J. Double‑blind evaluation of pramipexole extended‑release (ER) in early Parkinson’s disease // Neurology. 2009. Vol. 72, No. 11, Suppl. 3. P. A412–A413.
  8. Kvernmo T., Härtter S., Bürger E. A review of the receptor‑binding and pharmacokinetic properties of dopamine agonists // Clin. Ther. 2006. Vol. 28. P. 1065–1078.
  9. Mizuno Y., Yamamoto M., Kuno S. [et al.] Efficacy of pramipexole extended release (ER) and switching from pramipexole immediate release (IR) to ER in Japanese fdvanced Parkinson’s disease (PD) patients // Proceedings of the 18th WFN World Congress on Parkinson’s Disease and Related Disorders; Miami Beach, FL, USA. 2009. Poster 2.192.
  10. Möller J.C., Oertel W.H. Pramipexole in the treatment of Parkinson›s disease: new developments // Expert Rev. Neurother. 2005. Vol. 5. P. 581–586.
  11. Poewe W., Rascol O., Barone P. [et al.] Pramipexole extended‑release in early Parkinson’s disease // Neurology. 2011. Vol. 77. P. 759–766.


Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.